APAC Immunohematology Market size is slated to surpass USD 950 million by 2028, according to a latest forecast report by Graphical Research.

High diabetes prevalence, coupled with accelerated investments in the upgradation of diagnostic laboratories, is pushing the industry forecast. According to the International Diabetes Federation (IDF), the number of patients suffering from diabetes is expected to reach nearly 630 million by 2030, with every 3 in 4 adult patients being from low- and middle-income countries. Since diabetes screening involves the use of this equipment, more diagnostic laboratories, hospitals, and clinical practices are installing them.

The analyzers & systems segment is anticipated to represent over 30% of the market share by 2028. These devices will be adopted by more healthcare establishments, who are looking to strengthen their diagnostic capabilities. Regional diseases trends will influence the product consumption. For instance, with the prevalence of conditions such as malaria growing at an alarming pace in Southeast Asia, local authorities are extending financial aid for better access to prevention, treatment, and care.

Increased focus toward blood transfusion has encouraged regional governments to accelerate their efforts toward awareness campaigns. The government of India launched a nation-wide blood donation drive on September 6, 2022. More than 1,00,000 participants from across 3000 cities participated in the campaign, creating a new world record for the largest number of blood donations across the globe. India industry forecast will remain positive as the public hospital infrastructure is expanding in rural areas.

According to the Japan Society of Clinical Oncology, the prevalence of T cell lymphomas is comparatively higher in South Asia than in western countries in general, with the country accounting for a fair share of the disease burden. Since the diagnosis of this condition requires a complete blood count (CBC), all major hospitals in the region are equipped with devices that can process about 100 to 200 samples per hour. On the other hand, lower-volume labs are investing in compact designs that test up to 25 samples each day. Industry participants are offering LCD touchscreens integrated with latest software.

Browse detailed statistical insights from the report, “Asia Pacific Immunohematology Market Forecast 2028 By End Use (Hospitals, Diagnostic Laboratories, Blood Banks), By Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction, Erythrocyte-Magnetized Technology (EMT)), By Product (Analyzers & Systems, Reagents), Research Report, Country Outlook (Japan, China, India), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
https://www.graphicalresearch.com/industry-insights/1301/apac-immunohematology-market

China immunohematology industry size will grow at 5% CAGR between 2022 and 2028, due to growing number of advanced medical facilities for treating a host of health conditions is strengthening the sales of blood testing equipment in the nation. In 2021, the regional government tested thousands of Wuhan-based citizens for probing the origins of the SARS-CoV-2 virus. Since automatic hematology solutions streamline processes while managing such vast amounts of blood samples, more clinicians are investing in them.

The immunohematology in Asia Pacific market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2017 to 2028, for the following segments:

APAC Market, By Product

• Analyzers
• Reagents

APAC Market, By Technology

• Biochips
• Gel cards
• Microplates
• PCR
• Erythrocyte-magnetized technology

APAC Market, By End-use

• Hospitals
• Diagnostic laboratories
• Blood banks

The above information has been provided for the following countries:

• Asia Pacific
  • China
  • India
  • Japan
  • Australia